Campisi, G., Bedogni, A., Saia, G., Coppini, M., Mauceri, R., Fusco, V. (2024). Letter to editor regarding "bone modifying agents in breast cancer patients as adjuvant therapy and prevention of cancer treatment-induced bone loss (CTIBL): Evaluation of risk of medication-related osteonecrosis of the jaw (MRONJ)". SUPPORTIVE CARE IN CANCER, 32(10) [10.1007/s00520-024-08891-8].

Letter to editor regarding "bone modifying agents in breast cancer patients as adjuvant therapy and prevention of cancer treatment-induced bone loss (CTIBL): Evaluation of risk of medication-related osteonecrosis of the jaw (MRONJ)"

Campisi, Giuseppina;Coppini, Martina;Mauceri, Rodolfo
;
2024-10-01

1-ott-2024
Campisi, G., Bedogni, A., Saia, G., Coppini, M., Mauceri, R., Fusco, V. (2024). Letter to editor regarding "bone modifying agents in breast cancer patients as adjuvant therapy and prevention of cancer treatment-induced bone loss (CTIBL): Evaluation of risk of medication-related osteonecrosis of the jaw (MRONJ)". SUPPORTIVE CARE IN CANCER, 32(10) [10.1007/s00520-024-08891-8].
File in questo prodotto:
File Dimensione Formato  
DOC-20241001-WA0005..pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 559.9 kB
Formato Adobe PDF
559.9 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/657613
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact